|
|
Volumn 480, Issue 7377, 2011, Pages S43-S45
|
|
Tumorigenesis: Testing ground for cancer stem
a
a
NONE
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
B LYMPHOCYTE ANTIGEN;
BIOLOGICAL MARKER;
CELL ANTIBODY;
CELL ANTIGEN;
ANTIBODY;
ANTIGEN;
CANCER;
CHEMOTHERAPY;
DRUG RESISTANCE;
GENE EXPRESSION;
IMMUNITY;
MODEL VALIDATION;
MUTATION;
PROTEIN;
TUMOR;
ANTIBODY SPECIFICITY;
ARTICLE;
B LYMPHOCYTE;
CANCER REGRESSION;
CANCER RELAPSE;
CANCER RESEARCH;
CANCER STEM CELL;
CARCINOGENESIS;
CELL DIFFERENTIATION;
HUMAN;
IMMUNE SYSTEM;
IMMUNITY;
MEMORY CELL;
MULTIPLE MYELOMA;
NONHUMAN;
PLASMA CELL;
PRIORITY JOURNAL;
STEM CELL TRANSPLANTATION;
CELL TRANSFORMATION, NEOPLASTIC;
DRUG RESISTANCE, NEOPLASM;
HUMANS;
MODELS, BIOLOGICAL;
MULTIPLE MYELOMA;
NEOPLASTIC STEM CELLS;
RECURRENCE;
SURVIVAL RATE;
MARYLAND;
MASSACHUSETTS;
UNITED STATES;
|
|
EID: 83455238249
PISSN: 00280836
EISSN: None
Source Type: Journal
DOI: 10.1038/480S43a Document Type: Article |
|
Times cited : (37)
|
|
References (3)
|
